Oral low molecular weight heparin delivery by microparticles from complex coacervation.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  European journal of pharmaceutics and biopharmaceutics

• Publication date

  2007-11-01

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1016/J.EJPB.2007.04.004PMID 17540548
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Low molecular weight heparin nanoparticles: mucoadhesion and behaviour in Caco-2 cells

  2006cited by this paper
• N-Trimethylated Chitosan Chloride (TMC) Improves the Intestinal Permeation of the Peptide Drug Buserelin In Vitro (Caco-2 Cells) and In Vivo (Rats)

  2004cited by this paper
• Microencapsulation of Low Molecular Weight Heparin into Polymeric Particles Designed with Biodegradable and Nonbiodegradable Polycationic Polymers

  2003cited by this paper
• Anticoagulant activity of heparin following oral administration of heparin-loaded microparticles in rabbits.

  2002cited by this paper
• Treatment of venous thromboembolism

  2002cited by this paper
• In Vitro and In Vivo Evaluation of Oral Heparin–Loaded Polymeric Nanoparticles in Rabbits

  2002cited by this paper
• Influences of process parameters on preparation of microparticle used as a carrier system for omega - 3 unsaturated fatty acid ethyl esters used in supplementary nutrition.

  2001cited by this paper
• Orally administered unfractionated heparin with carrier agent is therapeutic for deep venous thrombosis.

  2000cited by this paper
• Treatment of venous thromboembolism.

  2000cited by this paper
• Characterization of microcapsules by confocal laser scanning microscopy: structure, capsule wall composition and encapsulation rate.

  2000cited by this paper
• Intestinal Absorption of Low Molecular Weight Heparin in Animals and Human Subjects

  2000cited by this paper
• Antithrombotic therapy for venous thromboembolic disease.

  1998cited by this paper
• Acylated non-α-amino acids as novel agents for the oral delivery of heparin sodium, USP

  1998cited by this paper
• Acylated non-alpha-amino acids as novel agents for the oral delivery of heparin sodium, USP.

  1998cited by this paper
• Oral delivery of anticoagulant doses of heparin. A randomized, double-blind, controlled study in humans.

  1998cited by this paper
• Assessment of outpatient treatment of deep-vein thrombosis with low-molecular-weight heparin.

  1998cited by this paper
• Preparation and stabilization of heparin/gelatin complex coacervate microcapsules.

  1997cited by this paper
• Comparison of poly(DL-lactide-co-glycolide) and polystyrene microsphere targeting to intestinal M cells.

  1993cited by this paper
• Antithrombotic therapy for venous thromboembolic disease.

  1992cited by this paper
• New heparin complexes active by intestinal absorption: I-multiple ion pairs with basic organic compounds.

  1989cited by this paper
• The Uptake and Translocation of Latex Nanospheres and Microspheres after Oral Administration to Rats

  1989cited by this paper
• Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine

  1987cited by this paper
• EFFECTS OF SELECTED VARIABLES ON THE EXTRACTABILITY OF OILS FROM COACERVATE CAPSULES.

  1964cited by this paper

• Gum arabic in drug delivery systems: A route-specific overview and functional insights.

  2025cites this paper
• Development of mucoadhesive 3D-printed Carbopol/Eudragit/SNAC tablets for the oral delivery of enoxaparin: In vitro and ex vivo evaluation.

  2024cites this paper
• Preparation of nanodelivery systems for oral administration of low molecular weight heparin

  2022cites this paper
• Protein-based nanoparticles for drug delivery purposes.

  2020cites this paper
• Low-Molecular-Weight Heparins: Reduced Size Particulate Systems for Improved Therapeutic Outcomes

  2018cites this paper
• Efficiently and Conveniently Heparin/ PEG-PCL Core-shell Microcarriers Fabrication and Optimization via Coaxial-Electrospraying

  2018cites this paper
• A quality by design (QbD) study on enoxaparin sodium loaded polymeric microspheres for colon‐specific delivery

  2017cites this paper
• Microparticles for oral delivery and cell encapsulation using membrane emulsification

  2017cites this paper
• Low molecular weight heparins for current and future uses: approaches for micro- and nano-particulate delivery

  2016cites this paper
• Strategies to Overcome Heparins’ Low Oral Bioavailability

  2016cites this paper
• Buccal delivery of low molecular weight heparin by cationic polymethacrylate nanoparticles.

  2016cites this paper
• Long Acting Parenteral Formulation of Heparin

  2016cites this paper
• Development of enoxaparin sodium polymeric microparticles for colon-specific delivery

  2015cites this paper
• Microparticles: Biopolymer Microparticles for Medicine and Regenerative Medicine

  2015cites this paper
• Pharmaceutical Applications of Various Natural Gums Natural gums

  2014cites this paper
• Advances in oral macromolecular drug delivery

  2014cites this paper
• Oral Delivery of Low Molecular Weight Heparin by Polyaminomethacrylate Coacervates

  2013cites this paper
• Application of multiple stepwise spinning disk processing for the synthesis of poly(methyl acrylates) coated chitosan-diclofenac sodium nanoparticles for colonic drug delivery.

  2013cites this paper
• In vitro and in vivo investigation of low molecular weight heparin–alginate beads for oral administration

  2013cites this paper
• Encapsulation of low molecular weight heparin (bemiparin) into polymeric nanoparticles obtained from cationic block copolymers: properties and cell activity.

  2013cites this paper
• Particles and powders: tools of innovation for non-invasive drug administration.

  2012cites this paper
• Nanoparticle-based clodronate delivery mitigates murine experimental colitis.

  2012cites this paper
• Recent advances in search of oral heparin therapeutics

  2012cites this paper
• Biomimetic solid lipid nanoparticles for oral bioavailability enhancement of low molecular weight heparin and its lipid conjugates: in vitro and in vivo evaluation.

  2011cites this paper
• Preparation of chitosan-based nanoparticles for delivery of low molecular weight heparin.

  2011cites this paper
• Microparticles as a strategy for low-molecular-weight heparin delivery.

  2011cites this paper
• Oral fondaparinux: use of lipid nanocapsules as nanocarriers and in vivo pharmacokinetic study

  2011cites this paper
• New challenges for a second-generation low-molecular-weight heparin: focus on bemiparin

  2010cites this paper
• Design and evaluation of a novel formulation prediction system.

  2010cites this paper
• Toward Effective Long-Term Prevention of Thromboembolism: Novel Oral Anticoagulant Delivery Systems

  2010cites this paper
• Strategies for oral delivery of macromolecule drugs

  2010cites this paper
• A study of some lipid-based drug delivery systems

  2010cites this paper
• Combined method of complex coacervation and electrospray for encapsulate preparation

  2010cites this paper
• Protein-polysaccharide complexes and coacervates.

  2009cites this paper
• Evaluating conditions for the formation of chitosan/gelatin microparticles

  2009cites this paper
• Pellets for oral administration of low-molecular-weight heparin

  2009cites this paper
• Granules in the improvement of oral heparin bioavailability.

  2009cites this paper
• Protein–polysaccharide complexes and coacervates

  2007cites this paper
• pH-sensitive microparticles for oral drug delivery

  2006cites this paper